Breaking News Instant updates and real-time market news.

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

13:35
06/23/17
06/23
13:35
06/23/17
13:35

Portola Pharmaceuticals trading resumes

  • 23

    Jun

  • 24

    Jun

PTLA Portola Pharmaceuticals
$38.25

-1.24 (-3.14%)

04/12/17
SBSH
04/12/17
NO CHANGE
Target $51
SBSH
Buy
Neurocrine approval reads positive for Portola, says Citi
Citi analyst Yigal Nochomovitz believes the approval of Neurocrine Biosciences' (NBIX) Ingrezza following a canceled advisory panel has a positive read-across to the ongoing FDA review for Portola Pharmaceuticals' (PTLA) betrixaban. The FDA had originally informed Portola to anticipate an advisory panel back in late December 2016, but in early February 2017 we learned the FDA was no longer requesting a panel, Nochomovitz tells investors in a research note. Ingrezza makes it four drugs out of four that got approved when a panel was canceled and there were no significant review issues identified by the FDA, the analyst adds, citing his analysis. The analyst notes he confirmed with Portola that no material issues were raised at the mid-cycle communication with the FDA on betrixaban. He keeps a Buy rating on Portola with a $51 price target.
04/19/17
SBSH
04/19/17
NO CHANGE
Target $51
SBSH
Buy
Citi says FDA analysis further supports Portola approval
Citi analyst Yigal Nochomovitz says his analysis of FDA precedence further supports approval of Portola Pharmaceuticals' novel blood thinner betrixaban. The FDA decision date is June 24. Two of the 29 drugs that were approved under Priority Review and no panel also missed their primary endpoints, Nochomovitz tells investors in a research note. He keeps a Buy rating on Portola with a $51 price target.
06/16/17
SBSH
06/16/17
NO CHANGE
Target $51
SBSH
Buy
Portola's interim cerdulatinib data 'look good,' says Citi
Citi analyst Yigal Nochomovitz says Portola Pharmaceuticals' interim cerdulatinib data in relapsed/refractory B-cell malignancies "look good" and provide upside not in his model. Success in developing cerdulatinib for this indication could provide additional upside for the shares, Nochomovitz tells investors in a research note. He keeps a Buy rating on Portola with a $51 price target.
06/23/17
SBSH
06/23/17
NO CHANGE
SBSH
Buy
FDA precedent points to decision on Portola's betrixaban coming today, says Citi
After examining 22 cases over the last three years where a PDUFA date for a drug's approval fell on a weekend or holiday, Citi analyst Yigal Nochomovitz found a "strong bias" for the FDA to issue its decision prior to, rather than on or after, the deadline date. Given that the PDUFA date for Portola's betrixaban falls on Saturday, June 24, Nochomovitz said he expects the FDA to issue its decision on betrixaban today, June 23. The analyst, who sees a high probability of approval, keeps a Buy rating on Portola shares.

TODAY'S FREE FLY STORIES

JNK

SPDR Barclays High Yield Bond

$36.79

-0.02 (-0.05%)

06:37
11/20/17
11/20
06:37
11/20/17
06:37
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$23.25

-0.02 (-0.09%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$1.94

0.04 (2.11%)

, COTY

Coty

$17.05

0.2 (1.19%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Recommendations
Avon Products, Coty analyst commentary  »

Coty may consider…

AVP

Avon Products

$1.94

0.04 (2.11%)

COTY

Coty

$17.05

0.2 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Downgrade
Ligand rating change  »

Ligand downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.47

-0.06 (-0.07%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$120.46

0.15 (0.12%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.39

0.93 (0.74%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$24.99

-0.16 (-0.64%)

, BA

Boeing

$262.26

-1.44 (-0.55%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Periodicals
Airbus faces challenges over stalled A380 Emirates deal, Reuters reports »

Airbus (EADSY) is facing…

EADSY

Airbus

$24.99

-0.16 (-0.64%)

BA

Boeing

$262.26

-1.44 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Altice: Majority investor Next does not hold any margin loan exposure to Altice »

Information service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$16.31

0.19 (1.18%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$12.56

0.45 (3.72%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice says will not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.14

-0.38 (-0.46%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

, ATUS

Altice USA

$19.86

-0.38 (-1.88%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Periodicals
Altice says not in preparation of cash raising by means of equity issuance »

Altice N.V. (ATCEY)…

ATCEY

Altice

ATUS

Altice USA

$19.86

-0.38 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice: Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$311.21

0.4 (0.13%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYAAY

Ryanair

$118.88

1.45 (1.23%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Initiation
Ryanair initiated  »

Ryanair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.40

0.01 (0.19%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$25.43

-0.17 (-0.66%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$1.94

0.04 (2.11%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Recommendations
Avon Products analyst commentary  »

Coty may consider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.71

-0.16 (-0.49%)

06:32
11/20/17
11/20
06:32
11/20/17
06:32
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$74.63

0.32 (0.43%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.82

0.23 (0.49%)

06:31
11/20/17
11/20
06:31
11/20/17
06:31
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$50.26

0.48 (0.96%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.34

-0.07 (-0.29%)

06:30
11/20/17
11/20
06:30
11/20/17
06:30
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.